Methodological considerations in comparative evaluations of pulsed field ablation systems for atrial fibrillation
Journal of Interventional Cardiac Electrophysiology · 07.07.2026 · 69 (8) · 2135-2136
DOI: 10.1007/s10840-026-02401-y ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, online erschienen am 07.07.2026. Verfasst von Muhammad Dawood Ghaffar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Federal Medical College, Shaheed Zulfiqar Ali Bhutto Medical University, G-8/4, Islamabad, Pakistan. muhammaddawoodghaffar@gmail.com. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Federal Medical College, Shaheed Zulfiqar Ali Bhutto Medical University, G-8/4, Islamabad, Pakistan. muhammaddawoodghaffar@gmail.com.
- Federal Medical College, Shaheed Zulfiqar Ali Bhutto Medical University, G-8/4, Islamabad, Pakistan.
- Department of Medicine, Quaid-e-Azam Medical College, Bahawalpur, Pakistan.
ORCID-Profile: Muhammad Dawood Ghaffar, Inshal Hussain, Muhammad Dayan Ghaffar
Zitieren
APA
Ghaffar, M. D., Hussain, I., & Ghaffar, M. D. (2026). Methodological considerations in comparative evaluations of pulsed field ablation systems for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 69(8), 2135-2136. https://doi.org/10.1007/s10840-026-02401-y
Vancouver
Ghaffar MD, Hussain I, Ghaffar MD. Methodological considerations in comparative evaluations of pulsed field ablation systems for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2026;69(8):2135-2136. doi:10.1007/s10840-026-02401-y
BibTeX
@article{Ghaffar2026,
author = {Ghaffar, Muhammad Dawood and Hussain, Inshal and Ghaffar, Muhammad Dayan},
title = {Methodological considerations in comparative evaluations of pulsed field ablation systems for atrial fibrillation},
journal = {Journal of Interventional Cardiac Electrophysiology},
year = {2026},
volume = {69},
number = {8},
pages = {2135--2136},
doi = {10.1007/s10840-026-02401-y}
}
EUVIMED